V. Grando

421 total citations
10 papers, 341 citations indexed

About

V. Grando is a scholar working on Hepatology, Epidemiology and General Health Professions. According to data from OpenAlex, V. Grando has authored 10 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 3 papers in General Health Professions. Recurrent topics in V. Grando's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver physiology and pathology (3 papers). V. Grando is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver physiology and pathology (3 papers). V. Grando collaborates with scholars based in France, United States and Italy. V. Grando's co-authors include Marilyn Rantz, Richard Madsen, Jane Bostick, Gregory F. Petroski, David R. Mehr, Meridean Maas, Lanis L. Hicks, Jill Scott, Vicki S. Conn and Rose Porter and has published in prestigious journals such as Annals of Oncology, The Gerontologist and Journal of Viral Hepatitis.

In The Last Decade

V. Grando

9 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Grando France 6 181 115 108 53 51 10 341
Juliana Chan United States 8 127 0.7× 72 0.6× 60 0.6× 157 3.0× 35 0.7× 14 358
Katharina Fierz Switzerland 9 82 0.5× 22 0.2× 28 0.3× 38 0.7× 4 0.1× 29 242
L A McNutt United States 9 91 0.5× 47 0.4× 86 0.8× 19 0.4× 3 0.1× 14 352
Medhat K. El-Shazly Egypt 12 89 0.5× 15 0.1× 82 0.8× 56 1.1× 4 0.1× 32 370
Linda Thélèmaque United States 15 170 0.9× 33 0.3× 135 1.3× 64 1.2× 3 0.1× 22 618
Charles P. Quesenberry United States 6 171 0.9× 3 0.0× 80 0.7× 68 1.3× 15 0.3× 9 353
Laura Holder Canada 10 78 0.4× 152 1.3× 188 1.7× 31 0.6× 2 0.0× 18 404
Nagah Selim Qatar 10 55 0.3× 14 0.1× 84 0.8× 59 1.1× 3 0.1× 49 299
Mei-Po Yip United States 10 202 1.1× 112 1.0× 138 1.3× 129 2.4× 18 507
Chyi‐Her Lin Taiwan 7 51 0.3× 6 0.1× 60 0.6× 50 0.9× 5 0.1× 10 343

Countries citing papers authored by V. Grando

Since Specialization
Citations

This map shows the geographic impact of V. Grando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Grando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Grando more than expected).

Fields of papers citing papers by V. Grando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Grando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Grando. The network helps show where V. Grando may publish in the future.

Co-authorship network of co-authors of V. Grando

This figure shows the co-authorship network connecting the top 25 collaborators of V. Grando. A scholar is included among the top collaborators of V. Grando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Grando. V. Grando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Grando, V., et al.. (2024). MORTALIDADE INFANTIL EM MENORES DE CINCO ANOS NO PARANÁ: UMA ANÁLISE EPIDEMIOLÓGICA DA INFLUÊNCIA DA PROMOÇÃO À SAÚDE NA ATENÇÃO PRIMÁRIA. Revista Ibero-Americana de Humanidades, Ciências e Educação. 10(7). 1758–1767.
2.
Decaens, Thomas, C. Barone, Eric Assénat, et al.. (2018). Efficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib. Annals of Oncology. 29. ix48–ix48. 5 indexed citations
3.
Decaens, Thomas, C. Barone, Eric Assénat, et al.. (2018). Phase II efficacy and safety data for the MET inhibitor tepotinib in patients (pts) with sorafenib-treated advanced hepatocellular carcinoma (HCC). Annals of Oncology. 29. viii235–viii235. 6 indexed citations
4.
Faivre, Sandrine, Jean‐Frédéric Blanc, Philippe Merle, et al.. (2016). PD-020 Tolerability and activity of second-line tepotinib, a potent and highly selective c-MET inhibitor, in patients with advanced hepatocellular carcinoma previously treated with sorafenib. Annals of Oncology. 27. ii109–ii109. 3 indexed citations
5.
Mahmoudi, Abdelhalim, N. Sellier, Jeanne Reboul‐Marty, et al.. (2011). Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study. Clinics and Research in Hepatology and Gastroenterology. 35(11). 731–737. 16 indexed citations
6.
Roulot, Dominique, Valérie Bourcier, V. Grando, et al.. (2006). Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. Journal of Viral Hepatitis. 14(7). 460–467. 88 indexed citations
7.
Bonilla, Nelly, Nathalie Barget, Muriel Andrieu, et al.. (2006). Interferon gamma‐secreting HCV‐specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis – ANRS HC EP07 study*. Journal of Viral Hepatitis. 13(7). 474–481. 14 indexed citations
8.
Rantz, Marilyn, Lanis L. Hicks, V. Grando, et al.. (2004). Nursing Home Quality, Cost, Staffing, and Staff Mix. The Gerontologist. 44(1). 24–38. 185 indexed citations
9.
Rantz, Marilyn, et al.. (2003). International comparison of quality indicators in United States, Icelandic and Canadian nursing facilities. International Nursing Review. 50(2). 79–84. 21 indexed citations
10.
Grando, V., et al.. (1994). [Ulcerative hemorrhagic proctitis caused by Klebsiella oxytoca after treatment with an amoxicillin-clavulanic acid combination].. PubMed. 18(5). 536–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026